MVX-5005

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameMVX-5005
Drug Alias NameMVX-5005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA damage stimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaveriX Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaveriX Oncology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A